Formulation and development of Serratiopeptidase enteric coated tablets and analytical method validation by UV Spectroscopy

Table 11

The percentage of the residual content of SRP enteric-coated tablets after agitation in simulated gastric fluid (pH 1.2) for 2 h.

Samples tested	Times (%)						Average (%)
	1	2	3	4	5	6
SRP formulated tablets	98.40	99.14	98.35	99.24	98.12	97.69	98.49
Market sample	98.22	97.10	96.42	94.14	96.29	95.42	96.27